Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Competitive exclusion of pathogenic oral bacteria by probiotics refers to the process whereby beneficial oral microbes (probiotics, such as *Lactobacillus plantarum*, *L. salivarius*, *S. salivarius*, and *Bifidobacterium*) suppress or outcompete pathogenic bacteria (e.g., *Streptococcus mutans*, *Porphyromonas gingivalis*, *Fusobacterium nucleatum*) in the oral cavity. This suppression is achieved through several mechanisms: competition for adhesion sites and nutrients, production of antimicrobial metabolites (such as acids, hydrogen peroxide, and bacteriocins), and formation of probiotic biofilms that prevent colonization of harmful bacteria. Some strains can modulate host immune responses or directly downregulate pathogenicity genes in harmful bacteria. This strategy aims to maintain oral microbiome balance, prevent dental caries and periodontal disease, and potentially aid in the prevention of oral cancer by restoring homeostasis and reducing chronic oral inflammation.
Competitive exclusion: probiotics compete for binding/adhesion sites and nutrients. Production of antimicrobial substances (acids, bacteriocins, hydrogen peroxide) suppresses pathogen growth. Biofilm formation by probiotics fills niches to prevent colonization by pathogens. Downregulation of pathogen virulence genes and inhibition of biofilm-associated gene expression. Local or systemic immunomodulation to reduce oral inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Competitive exclusion of pathogenic oral bacteria by probiotics.